Christopher Liu

Stock Analyst at Leerink Partners

(2.98)
# 1,554
Out of 5,042 analysts
9
Total ratings
83.33%
Success rate
37.9%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Christopher Liu

Exelixis
Oct 21, 2025
Upgrades: Outperform
Price Target: $48
Current: $38.72
Upside: +23.97%
Lyell Immunopharma
Sep 26, 2025
Initiates: Buy
Price Target: $20
Current: $17.64
Upside: +13.38%
Adagene
Sep 18, 2025
Initiates: Buy
Price Target: $9
Current: $1.79
Upside: +402.77%
Genelux
Jul 21, 2025
Initiates: Buy
Price Target: $10
Current: $7.82
Upside: +27.88%
Relay Therapeutics
Dec 4, 2024
Maintains: Outperform
Price Target: $19$18
Current: $6.86
Upside: +162.39%
IDEAYA Biosciences
Nov 5, 2024
Downgrades: Market Perform
Price Target: $41$27
Current: $29.18
Upside: -7.47%
Nuvalent
Aug 8, 2023
Initiates: Market Perform
Price Target: $42
Current: $93.39
Upside: -55.03%